CD14 and lymphoma: A subset of MDSC, characterized as monocytic CD14+ cells with low levels of lack of the antigen presenting HLA-DR molecules (CD14+HLA-DRlow/neg (DIM)) [43] has been associated as a negative prognostic factor for survival circulating in the peripheral blood of lymphoma patients [44].